FOCUS trial data show similar fremanezumab efficacy in Europe and the USA

An exploratory analysis from the Phase 3b FOCUS study of fremanezumab in episodic and chronic migraine has shown comparable efficacy in patients in the Czech Republic, Finland and the USA.

Read more »

IHS-GPAC to initiate workplace support programmes for employees with migraine

The International Headache Society Global Patient Advocacy Coalition (IHS-GPAC) is developing a series of strategies and resources to raise awareness and support patients with migraine in the workplace.

Read more »

Galcanezumab study sheds light on acute and preventive treatment choices for chronic cluster headache

Nearly three quarters of participants in a Phase 3 trial of galcanezumab in chronic cluster headache were using one preventive at baseline and nearly a quarter were using two, with verapamil the most common choice, according to a new evaluation of the study.

Read more »

Substantial migraine burden across Eurasian countries

Migraine is a substantial clinical and economic burden in Eurasian countries, though use of preventive migraine medication is low, according to a systematic literature review reported for China, Israel, Russia, South Korea, and Turkey.

Read more »

Raised CGRP identified in painful eye condition

Raised serum CGRP levels may indicate a migrainous aetiology for recurrent painful ophthalmoplegic neuropathy (RPON)/ophthalmoplegic migraine (OM) and may prove useful as a diagnostic biomarker.

Read more »